Arrowhead Pharmaceuticals Inc. buy Bank of America Co.
Start price
01.12.25
/
50%
€47.40
Target price
01.12.26
€53.46
Performance (%)
27.43%
Price
29.04.26
€60.40
Summary
This prediction is currently active. The prediction currently has a performance of 27.43%. This prediction currently runs until 01.12.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Arrowhead Pharmaceuticals Inc. | -4.370% | -4.370% |
| iShares Core DAX® | -1.499% | 7.705% |
| iShares Nasdaq 100 | 1.380% | 16.275% |
| iShares Nikkei 225® | -1.992% | 13.113% |
| iShares S&P 500 | 0.345% | 10.816% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals (NASDAQ:ARWR) had its price target raised by analysts at Bank of America Corporation from $42.00 to $62.00. They now have a "buy" rating on the stock.
Ratings data for ARWR provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€59.64
09.12.25
09.12.25
€69.55
09.12.26
09.12.26
1.27%
29.04.26
29.04.26
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€28.47
02.01.24
02.01.24
€33.76
02.01.25
02.01.25
-33.26%
03.01.25
03.01.25
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€21.76
04.12.23
04.12.23
€26.71
04.12.24
04.12.24
1.56%
05.12.24
05.12.24